Every reference-peptide label carries a purity percentage, but 95%, 98%, and 99% are not interchangeable claims. Each is an area-percent by RP-HPLC at 214 nm — capping related impurities at roughly 5%, 2%, and 1%.
None of the three mean what most buyers assume. "Research-grade" is not a regulated designation, so the label alone is not evidence. A percentage with no method attached is not data. Knowing how the Purity field appears on a COA is what turns the number into evidence.
This note covers what the number measures, how the tiers differ, and which bench tasks each tier is fit for. Every material discussed here is a reference standard for laboratory research only.
What "purity by HPLC" actually measures
HPLC purity is an area-percent: the target peptide's peak area divided by the total integrated peak area, times 100. It ranks the target against the other UV-absorbing peptide-related species in the same run — and against nothing else.
Two purity numbers are therefore only comparable when both name the same technique, detector, and wavelength. "≥ 99.0% by RP-HPLC, UV 214 nm" is a specification. "99% purity" on its own is a sentence. The parameters that make a chromatographic result comparable at all — resolution, symmetry factor, repeatability, and the rest of system suitability — are fixed by USP General Chapter ⟨621⟩ Chromatography.
Area-percent, not weight-percent
Area-percent purity is a ratio of chromatographic peak areas, not a ratio of masses in the vial.
Purity (%) = (main peak area ÷ sum of all integrated peak areas) × 100
The denominator holds only what the detector saw and the integrator counted. For a reference peptide at 214 nm, that is the target plus its peptide-related impurities: deletion sequences, truncated sequences, oxidation products, and deamidation products. Water, bound salts, and trifluoroacetate counter-ions produce no peak, so they never enter the calculation.
That exclusion drives the most misread fact in the category. A 99.0% area-percent number is not a claim that 99% of the vial's mass is peptide. Those are two separate determinations, and purity is not net peptide content.
Why 214 nm, and what 280 nm adds
214 nm is the default detection wavelength because it reads the amide bond of the peptide backbone, which is sequence-nonspecific. Essentially every peptide-related species absorbs there, so the chromatogram shows the full related-impurity picture rather than a subset.
280 nm responds only to aromatic side chains — tryptophan, tyrosine, and weakly phenylalanine. A sequence carrying none of those residues is close to invisible at 280 nm. That makes it a confirmatory trace for cross-checking a peak's character, not a primary purity channel.
One assumption is baked into every area-percent number: that the target and its related impurities have similar molar absorptivity at the detection wavelength. That approximation holds for closely related sequences and is not universally valid — one more reason the method belongs on the certificate. For the mechanics, start with reading peaks, retention time, and area-percent.
The three tiers: ≥ 95%, ≥ 98%, ≥ 99%
The three tiers set a ceiling on related-impurity burden — roughly 5%, 2%, and 1% by area-percent. They are commonly-cited industry conventions, not thresholds mandated by any regulatory body. No agency defines "research-grade" as a number.
It is worth seeing what a genuinely standardized material looks like by contrast. USP Reference Standards and NIST Standard Reference Materials are each defined by a documented, traceable characterization campaign and ship with a certificate stating assigned values and uncertainty. "Research-grade" carries no such definition. That is why the evidence has to come from the lot document rather than the adjective.
| Tier (by RP-HPLC, UV 214 nm) | Max related-impurity burden (area-%) | What it constrains | Typically fit for (at the bench) |
|---|---|---|---|
| ≥ 95% | ≤ ~5% | Target vs peptide-related impurities, area-percent | Qualitative identity, early method scouting, screening |
| ≥ 98% | ≤ ~2% | Same ratio, tighter interfering-peak constraint | Quantitative method development, comparative in-vitro assays |
| ≥ 99% | ≤ ~1% | Target dominates the chromatogram | Calibration standards, lot-release comparison, quantitative reference — elev8 catalog floor |
Area-percent purity is the target peptide relative to other UV-absorbing species. It is not the peptide fraction of the vial by mass. It says nothing about endotoxin, salts, or residual solvents. Tiers are commonly-cited industry conventions, not a single regulatory standard.
≥ 95%: the screening and method-development floor
≥ 95% is the lowest tier commonly marketed as research-grade. It leaves up to about 5% of the integrated area as peptide-related impurity — workable when the question is qualitative: is the target present, and does it elute where expected.
Where ≥ 95% breaks down is quantitation. A 5% burden spread across several partially resolved peaks can co-integrate with the target and shift the number you rely on. Use this tier for scouting a gradient or confirming identity — not for a value another laboratory must reproduce.
≥ 98%: the quantitative-work benchmark
≥ 98% is the tier most quantitative bench work standardizes on, and it is what "is 98% good enough" usually comes down to. At ≤ 2% total related impurity, individual peaks stay small. A closely eluting species is less likely to merge into the target during integration.
For method development, comparative in-vitro assays, and routine analytical work, ≥ 98% by RP-HPLC is a defensible floor. For material that will itself serve as the yardstick, go a tier higher.
≥ 99%: the reference-standard tier
≥ 99% leaves ≤ 1% of the chromatogram to everything that is not the target. That matters when the chromatogram is the evidence: a new peak in a later run reads as unambiguous rather than lost among impurities that were already there.
This is the tier for calibration curves, lot-release comparison, and any workflow whose write-up will be read by an auditor or a journal reviewer. It is also the floor elev8 holds across the catalog.
What each tier is fit for at the bench
Match the tier to the task, not to the grade name: ≥ 95% for qualitative work, ≥ 98% for quantitative method development, ≥ 99% for anything that will itself serve as a reference.
- Qualitative identity, presence-absence checks, gradient scouting → ≥ 95% by RP-HPLC.
- Method development, comparative in-vitro assays, routine quantitative measurement → ≥ 98%.
- Calibration standards, lot-release comparison, purity comparison against another sample, stability-indicating methods → ≥ 99%.
Two qualifiers matter more than the tier name itself.
First, a tier is a claim until a lot-specific certificate supports it. A catalog page reading "≥ 99%" and a COA reporting 99.4% against the lot number on your vial are different artifacts. What reference-grade means in practice is that the second one exists.
Second, a tier is a floor, not a measurement. "≥ 98.0%" says the vendor will stand behind 98.0%; your lot may measure 98.2%, or 99.6%. When a calculation depends on the absolute number, use the value printed on the COA — never the catalog floor.
Purity is not net peptide content
A vial can report 99.0% by RP-HPLC and still be well under 99% peptide by mass. HPLC purity is blind to anything that does not absorb at the detection wavelength: residual water from lyophilization, bound salts, and trifluoroacetate counter-ions all add mass without adding peak area.
Net peptide content is the separate determination that answers the mass question, typically by amino-acid analysis under USP ⟨1052⟩ or a nitrogen-based method such as USP ⟨1057⟩ Total Protein Assay. It is normally a lower number than HPLC purity, because it accounts for the non-peptide fraction the chromatogram never sees.
So two vials at an identical 99.0% area-percent can hold materially different peptide mass. Preparing a solution at a known concentration requires net peptide content, not area-percent purity. Purity is also not a potency measurement; it is a chromatographic ratio and nothing more. That distinction gets its own walkthrough in purity is not net peptide content.
What the purity percentage does not capture
An area-percent number describes UV-absorbing peptide-related species and nothing beyond them. Several classes of contaminant are invisible to the 214 nm detector, and no purity tier speaks to them.
- Residual solvents from synthesis and purification — a separate determination, usually by gas chromatography, with limits and classes set out in USP ⟨467⟩ Residual Solvents.
- Heavy metals and elemental impurities — determined by ICP-MS, not by HPLC, against the procedures harmonized as ⟨233⟩ Elemental Impurities—Procedures and the limits in ICH Q3D(R2).
- Bacterial endotoxin and sterility — endotoxin and sterility are separate assays, with their own units and their own certificates. They run under USP ⟨85⟩ Bacterial Endotoxins Test and USP ⟨71⟩ Sterility Tests respectively.
Identity is the other gap. Area-percent tells you one species dominates the chromatogram, not that the species is the sequence printed on the label. That is what mass spectrometry adds — the identity that purity alone does not confirm. A certificate reporting purity with no orthogonal identity check is describing a large peak, not a known compound.
elev8's published specification
The elev8 catalog is held to a purity floor of ≥ 99.0% by RP-HPLC, UV 214 nm. Identity is confirmed by mass spectrometry, and a COA is issued per lot by an independent analytical laboratory. Lots below the floor do not ship — the catalog reflects what passed release.
A specification is only as strong as the document behind it, so every lot number maps to a retrievable COA. You can browse per-lot certificates of analysis and check our reference-standard catalog for a given item. The hub post covers how the Purity field appears on a COA field by field. And when a vendor quotes a number with no method and no lot, a bare percentage with no method is a red flag.
Frequently asked questions
What does peptide purity mean on a COA?
It is the area-percent from RP-HPLC: the target peptide's peak area divided by the total integrated peak area, usually measured at 214 nm. It describes the target relative to the other peptide-related species the detector saw. It is not the fraction of the vial's mass that is peptide, and it says nothing about salts, residual solvents, or endotoxin.
Is 98% purity good enough for research?
For method development and comparative in-vitro work, ≥ 98% by RP-HPLC is a widely used benchmark. At ≤ 2% related-impurity burden, interfering peaks rarely swamp the target during integration. For a quantitative calibration standard or a lot-release comparison, a ≥ 99% tier is preferred, so any new impurity peak is unambiguous. Match the tier to your documentation burden.
What is the difference between 95%, 98%, and 99% peptide purity?
The number sets the maximum related-impurity burden the material may carry by area-percent — roughly ≤ 5%, ≤ 2%, and ≤ 1% respectively. Higher tiers leave less room for co-eluting or interfering peaks in the chromatogram, which matters most in quantitative work. None of the three is a claim about suitability for any use in or on a living system.
Does HPLC purity tell you how much peptide is in the vial?
No. HPLC purity is blind to water, bound salts, and trifluoroacetate counter-ions, because none of them produce a peak at 214 nm. A vial can report 99.0% area-percent purity and still be a lower percentage peptide by mass. That mass fraction is a separate determination called net peptide content, run by amino-acid analysis or a nitrogen-based method.
Is "research-grade" a regulated purity standard?
No. "Research-grade" and "reference-grade" are unregulated descriptors — any vendor can print either one on any label. The only evidence behind a purity claim is a lot-specific certificate of analysis. It should name the analytical method, the detection wavelength, the measured value, and the independent laboratory that ran it.
elev8 Labs products are reference standards for laboratory research only. Not for human consumption.